GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Capex-to-Revenue

Aker BioMarine ASA (OSL:AKBM) Capex-to-Revenue : 0.06 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Aker BioMarine ASA's Capital Expenditure for the three months ended in Mar. 2024 was kr-49.88 Mil. Its Revenue for the three months ended in Mar. 2024 was kr830.93 Mil.

Hence, Aker BioMarine ASA's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.06.


Aker BioMarine ASA Capex-to-Revenue Historical Data

The historical data trend for Aker BioMarine ASA's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Capex-to-Revenue Chart

Aker BioMarine ASA Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.08 0.31 0.17 0.15

Aker BioMarine ASA Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.08 0.11 0.29 0.06

Competitive Comparison of Aker BioMarine ASA's Capex-to-Revenue

For the Packaged Foods subindustry, Aker BioMarine ASA's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aker BioMarine ASA's Capex-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aker BioMarine ASA's Capex-to-Revenue falls into.



Aker BioMarine ASA Capex-to-Revenue Calculation

Aker BioMarine ASA's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-520.085) / 3537.214
=0.15

Aker BioMarine ASA's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-49.877) / 830.927
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aker BioMarine ASA  (OSL:AKBM) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Aker BioMarine ASA Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aker BioMarine ASA (OSL:AKBM) Business Description

Traded in Other Exchanges
Address
Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines